BOSTON SCIENTIFIC CORP
No SEC Form 4 filings for $BSX in the last 30 days.
Allshores, a Bermuda Stock Exchange–listed insurer, announced a dividend of 40 cents per share for the first quarter of 2026, according to the company. The ex-dividend date is June 3 and the payment date is June 26. The Royal Gazette/BSX Index was unchanged at 3,540.87 due to no trading activity, and Butterfield Bank shares did not trade because the NYSE was closed for Memorial Day.
Abbott Laboratories is expanding its focus on digital health by introducing new cardiovascular diagnostics and wearable devices like its Lingo biomarker. This strategic shift aims to deepen customer relationships and drive long-term revenue growth, despite potential near-term pressures on margins from increased R&D and software investments. Investors are encouraged to monitor the adoption rates of these new technologies and how Abbott balances its digital health spending with existing product lines.
Medtronic is set to acquire SPR Therapeutics for approximately $650 million, enhancing its offerings in peripheral nerve stimulation (PNS) for chronic pain management. This acquisition will integrate SPR's SPRINT PNS System, an FDA-cleared temporary therapy, into Medtronic's neuromodulation solutions. The deal aims to provide earlier intervention options for chronic pain patients and is expected to close in the first half of Medtronic's fiscal year 2027.
